Konica Minolta Healthcare Americas is partnering with RegenLab to distribute its regenerative medicine portfolio of bioinjectable products to the musculoskeletal, pain management, radiology, and veterinary markets in the U.S. and Canada.
RegenLab's product line includes preparation devices for platelet-rich plasma and other blood cell therapies that are delivered using ultrasound guidance. The products are designed for sports medicine, orthopedics, and pain management.
For Konica, the deal is designed to expand its UGPro program, which combines ultrasound imaging with targeted therapies and hands-on education to help improve patient outcomes.
